Lipids in Health and Disease

Scope & Guideline

Unlocking the secrets of lipids in health and disease.

Introduction

Welcome to the Lipids in Health and Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Lipids in Health and Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationLIPIDS HEALTH DIS / Lipids Health Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Lipids in Health and Disease' aims to advance the understanding of lipid metabolism and its implications for health and disease. It publishes research on various aspects of lipid biology, including the role of lipids in metabolic diseases, cardiovascular health, and other related conditions.
  1. Lipid Metabolism and Disease:
    The journal focuses on the relationship between lipid metabolism and various diseases, particularly metabolic syndrome, cardiovascular diseases, and liver conditions. It seeks to uncover the mechanisms by which lipid dysregulation contributes to disease pathogenesis.
  2. Epidemiological Studies:
    There is a strong emphasis on population-based studies that explore the associations between lipid levels, dietary intake, and health outcomes. This includes cross-sectional studies, cohort analyses, and systematic reviews that provide insights into lipid-related health risks in different populations.
  3. Molecular Mechanisms of Lipid Action:
    Research that delves into the molecular and cellular mechanisms by which lipids influence health is a core area of focus. This includes studies on lipid signaling pathways, gene expression related to lipid metabolism, and the impact of lipids on cellular functions.
  4. Clinical Interventions and Therapies:
    The journal also publishes studies on clinical interventions aimed at modifying lipid levels, such as dietary changes, pharmacological treatments, and lifestyle modifications. It evaluates the efficacy and safety of these interventions in managing lipid-related disorders.
  5. Innovative Methodologies:
    Utilizing cutting-edge methodologies, including machine learning and advanced lipidomic techniques, the journal highlights novel approaches to studying lipid metabolism and its clinical implications.
Recent publications in 'Lipids in Health and Disease' indicate a shift towards emerging themes that reflect current societal health challenges and advances in research methodologies. These trends highlight the journal's responsiveness to evolving scientific inquiries.
  1. Integration of Lipids and Inflammation:
    There is an increasing focus on the relationship between lipid metabolism and inflammation, particularly how lipid profiles can influence inflammatory pathways in various diseases, including metabolic syndrome and cardiovascular diseases.
  2. Lipidomics and Precision Medicine:
    The application of lipidomics in precision medicine is gaining traction. Research is increasingly looking at how individual lipid profiles can inform personalized treatment strategies for conditions like diabetes and cardiovascular diseases.
  3. Impact of Lifestyle Factors on Lipid Profiles:
    Studies examining the effects of lifestyle interventions, such as diet, exercise, and sleep, on lipid profiles are trending. This reflects a growing interest in holistic and preventive approaches to managing lipid-related health issues.
  4. Mendelian Randomization Studies:
    The use of Mendelian randomization to infer causality between lipid levels and health outcomes is becoming more prevalent, providing robust evidence for the role of lipids in various diseases.
  5. Longitudinal Studies on Lipid Dynamics:
    Emerging research is increasingly longitudinal, exploring changes in lipid profiles over time and their implications for long-term health outcomes, particularly in aging populations.

Declining or Waning

While 'Lipids in Health and Disease' continually evolves, some areas of research have shown a decline in publication frequency, suggesting a potential waning interest or saturation of studies in those specific themes.
  1. Basic Lipid Chemistry:
    Research focused solely on basic lipid chemistry without direct implications for health or disease has seen a decline. The journal has shifted towards studies that connect lipid chemistry with clinical outcomes or disease mechanisms.
  2. Animal Models without Clinical Correlation:
    Papers primarily using animal models to study lipid metabolism without translating findings to human health or clinical relevance have decreased. The trend is towards studies that can bridge animal research with human applications.
  3. Single-Disease Focus:
    There is a noticeable decrease in studies focusing exclusively on a single disease, such as isolated cardiovascular diseases. The journal now favors research that considers the interplay between multiple conditions and their lipid-related aspects.
  4. Overlapping Indices for Lipid Assessment:
    The use of overlapping or redundant lipid indices for assessing cardiovascular risk has diminished, as the field moves towards more standardized and clinically relevant measures.
  5. Traditional Epidemiological Approaches:
    More traditional epidemiological approaches that lack innovative analytical methods or fail to incorporate modern statistical techniques are less common, as the journal embraces more sophisticated methodologies.

Similar Journals

BIOCHIMIE

Advancing the Frontiers of Biochemistry and Medicine
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0300-9084Frequency: 12 issues/year

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

Journal of Clinical Lipidology

Transforming understanding in lipidology and its clinical applications.
Publisher: ELSEVIER SCIENCE INCISSN: 1933-2874Frequency: 6 issues/year

Journal of Clinical Lipidology, published by Elsevier Science Inc, is a leading platform dedicated to advancing the understanding of lipidology and its impact on cardiovascular health. With an ISSN of 1933-2874 and E-ISSN 1876-4789, this esteemed journal boasts a remarkable Q1 ranking in key medical categories, including Cardiology and Cardiovascular Medicine, Internal Medicine, and Nutrition and Dietetics, solidifying its position as a vital resource for the latest research and clinical practices. This journal not only serves as a repository for groundbreaking studies but also provides insights into complex interactions between lipid metabolism and chronic diseases, including diabetes and obesity. Researchers, practitioners, and students will find a wealth of carefully vetted articles that drive innovation and improve patient outcomes in lipid management. Although it does not currently offer open access, the Journal of Clinical Lipidology ensures high visibility through rigorous peer review and a commitment to quality, making it an essential read for anyone invested in the future of lipidology.

LIPIDS

Unraveling lipid mysteries since 1966.
Publisher: WILEYISSN: 0024-4201Frequency: 6 issues/year

LIPIDS is a renowned peer-reviewed journal published by Wiley, dedicated to the field of lipid research, encompassing biochemistry, molecular biology, and organic chemistry. With its roots dating back to 1966 and a commitment to advancing knowledge until 2024, this journal serves as a vital platform for sharing significant findings in lipid biochemistry and its applications in health and disease. Although it currently does not offer Open Access options, it maintains a respectable standing with a Q3 ranking in Biochemistry and Organic Chemistry, and a Q4 ranking in Cell Biology based on the 2023 category quartiles. Additionally, its Scopus rankings reflect a solid position within the organic chemistry and biochemistry subfields. Published from Germany, LIPIDS caters to researchers, professionals, and students eager to explore the roles of lipids in biological processes and innovatory applications in various scientific disciplines.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Exploring the frontiers of hormonal regulation.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1849Frequency: 12 issues/year

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

Molecular Therapy Nucleic Acids

Pioneering the next generation of nucleic acid therapies.
Publisher: CELL PRESSISSN: 2162-2531Frequency: 4 issues/year

Molecular Therapy Nucleic Acids is a premier open-access journal published by CELL PRESS, dedicated to advancing the field of molecular medicine through the innovative application of nucleic acid-based therapies. Since its inception in 2012, this journal has become an essential resource for researchers and professionals in drug discovery and molecular medicine, reflected in its status as a Q1 journal in both categories for 2023. With a notable impact factor and high rankings in Scopus, including #8 out of 157 in Drug Discovery and #16 out of 178 in Molecular Medicine, it serves to disseminate groundbreaking research and foster collaborations among scientists worldwide. The journal's comprehensive scope encompasses a wide variety of topics, including gene therapy, RNA interference, and CRISPR technology, ensuring that it remains at the forefront of scientific excellence. With open access availability, Molecular Therapy Nucleic Acids actively promotes the widespread dissemination of knowledge, making its crucial insights accessible to students, researchers, and industry professionals alike.

PROGRESS IN LIPID RESEARCH

Leading the Charge in Lipid Research Excellence
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0163-7827Frequency: 4 issues/year

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.

BIOCHEMICAL JOURNAL

Empowering Researchers with Cutting-Edge Insights
Publisher: PORTLAND PRESS LTDISSN: 0264-6021Frequency: 24 issues/year

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

AMERICAN JOURNAL OF CLINICAL NUTRITION

Transforming health care with evidence-based nutrition insights.
Publisher: ELSEVIER SCIENCE INCISSN: 0002-9165Frequency: 12 issues/year

The American Journal of Clinical Nutrition, published by Elsevier Science Inc, stands as a premier academic platform dedicated to advancing knowledge in the fields of clinical nutrition and dietary science. With its roots tracing back to 1952, this prestigious journal boasts rigorous peer-reviewed research, providing vital insights and evidence-based findings that cater to the ever-evolving landscape of nutrition and health care. Affiliated with a strong reputation, the journal holds an impressive impact factor and is ranked in the top quartile (Q1) in both Nutrition and Dietetics and Medicine (miscellaneous), underscoring its significance in the academic community. With current Scopus rankings placing it #7 in Nursing and Nutrition and Dietetics and #20 in Medicine, it serves as an essential resource for researchers and practitioners seeking to stay at the forefront of clinical nutritional science. This journal not only disseminates groundbreaking research but also fosters collaborations among scholars, enhancing the clinical implications of nutrition practices globally. Access to the journal may vary, given its non-open access format; however, its contributions remain indispensable to professionals and students alike striving to deepen their understanding of clinical nutrition.

Journal of Endocrinology and Metabolism

Fostering dialogue on critical issues in endocrinology and metabolism.
Publisher: ELMER PRESS INCISSN: 1923-2861Frequency: 4 issues/year

Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.

CURRENT OPINION IN LIPIDOLOGY

Pioneering critical discussions in lipid research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0957-9672Frequency: 6 issues/year

Current Opinion in Lipidology is a premier journal published by Lippincott Williams & Wilkins, offering critical insights into the ever-evolving landscape of lipid research. With an impressive convergence spanning from 1990 to 2024, this journal serves as an essential platform for researchers, clinicians, and professionals dedicated to the study of lipids in relation to cardiovascular health, endocrinology, and metabolism. The journal currently holds a distinguished Q1 ranking in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics, showcasing its significant impact in these fields. Additionally, it ranks in the Q2 quartile for Cell Biology and Molecular Biology, underlining its comprehensive approach to lipidology. Though not open access, the content is rich with cutting-edge reviews, clinical studies, and expert opinions that aim to advance knowledge and practice in lipid metabolism, making it a valuable resource for anyone seeking to stay abreast of the latest developments in lipid research.